ABBOTT PARK, Ill., Sept. 4, 2024 /PRNewswire/ -- Abbott announced today it has initiated a pivotal clinical trial, called the TRANSCEND study, to evaluate the use of the company's deep brain ...
Deep–Brain Stimulation (DBS) has become an effective means of treating a variety of neurological conditions. Most DBS systems work are "open-loop," and apply constant stimulation over the lifetime of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results